ANTIBIOTIC PRESCRIBING PRACTICES AMONG HOSPITALIZED PATIENTS AT A NATIONAL ANTIMICROBIAL CONSUMPTION NETWORK SITE IN NORTH INDIA: A WHO POINT PREVALENCE SURVEY
Main Article Content
Keywords
Point Prevalence Survey (PPS), National Antimicrobial Consumption Network (NAC-NET), Antimicrobial resistance (AMR), AWaRe
Abstract
Background: Antimicrobial resistance (AMR) is a major global threat driven by inappropriate antibiotic use. Monitoring and analyzing antimicrobial prescribing practices and consumption patterns among hospitalized patients is essential for developing effective strategies to combat AMR.
Objective: This study aimed to evaluate antibiotic prescribing patterns among hospitalized patients at a National Antimicrobial Consumption Network (NAC-NET) site.
Methods: A cross-sectional study was conducted at GSVM Medical College, Kanpur, in February 2022, applying the standard guidelines described by the WHO Methodology for PPS on Antibiotic use among inpatients. Data on antimicrobial use, indications, routes, and WHO AWaRe classification were collected using structured forms and analyzed descriptively.
Results: Of 341 eligible inpatients, 93.3% were on at least one antibiotic, with a total of 586 antibiotics prescribed (average: 1.7 per patient). Injectable antibiotics accounted for 90.1% of use. Surgical prophylaxis (43%) and community-acquired infections (28%) were the most common indications. Only 11.9% of prescriptions included a stop/review date. Third-generation cephalosporins were the most frequently used (42%). The watch group antibiotics comprised 62.9% of prescriptions, while the Access group antibiotics were used in 31.8%—below the WHO target of ≥60%. Double coverage for Gram-negative organisms (28.3%) and double anaerobic coverage (14.1%) was frequently observed. Definitive therapy was rarely documented (0.3%).
Conclusion: The study identified a high rate of antibiotic use accompanied by inadequate adherence to stewardship principles. Findings underscore the need for institutional antibiotic guidelines, promotion of microbiological diagnostics, appropriate surgical prophylaxis, and increased use of Access group antibiotics to align with WHO recommendations.
References
2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. Wellcome Trust and HM Government; 2016 [cited 2025 Jan 30]. Available from: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
3. Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470.
4. National Centre for Disease Control, Ministry of Health & Family Welfare, Government of India. National Action Plan on Antimicrobial Resistance (NAP AMR) 2017 2021 [Internet]. New Delhi: NCDC; April 2017 [cited 2025 Sep 20]. Available from: https://ncdc.mohfw.gov.in/wp-content/uploads/2024/03/File645.pdf
5. WHO. Global Action Plan on Antimicrobial Resistance. 2015. Available from: https://apps.who.int/iris/handle/10665/193736
6. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2017-2018. Geneva: World Health Organization; 2018.
7. World Health Organization. Antimicrobial resistance. [Internet]. Geneva: World Health Organization; [updated 2023 Oct 11; cited 2025 Jan 30]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
8. World Health Organization. Strengthening health systems to improve health outcomes: WHO’s framework for action. [Internet]. Geneva: World Health Organization; 2018 [cited 2025 Jan 30]. Available from: https://iris.who.int/bitstream/handle/10665/280063/WHO-EMP-IAU-2018.01-eng.pdf?sequence=1
9. National Centre for Disease Control. NAC-NET report on antimicrobial consumption. [Internet]. New Delhi: National Centre for Disease Control; 2024 Dec [cited 2025 Jan 30]. Available from: https://ncdc.mohfw.gov.in/wp-content/uploads/2024/12/NAC-NET_report-on-antimicrobial-consumption.pdf
10. World Health Organization. AWaRe classification of antibiotics for evaluation and monitoring of use. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/2021-aware-classification
11. Umeokonkwo, C.D.; Madubueze, U.C.; Onah, C.K.; Okedo-Alex, I.N.; Adeke, A.S.; Versporten, A.; Goossens, H.; Igwe-Okomiso, D.; Okeke, K.; Azuogu, B.N.; et al. Point prevalence survey of antimicrobial prescription in a tertiary hospital in South East Nigeria: A call for improved antibiotic stewardship. J. Glob. Antimicrob. Resist. 2019, 17, 291–295.
12. Panditrao AM, Shafiq N, Chatterjee S, Pathak A, Trivedi N, Sadasivam B, Kshirsagar N, Kaul R, Biswal M, Kakkar A, Malhotra S, Arora P, Talati S, Dhaliwal N, Hazra A, Jhaj R, Najmi A, Pandey N, Chakraverty R, Pathan S, Chauhan J, Mathur A; ASPIRE Study Group. A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India. J Antimicrob Chemother. 2021;76(4):1094-1101. https://doi.org/10.1093/jac/dkaa533
13. Chakraverty R, Samanta K. A point prevalence survey study (PPS) of antimicrobial consumption in a tertiary care super-speciality hospital of West Bengal. Indian J Pharm Pharmacol 2021;8(3):200-204. https://doi.org/10.18231/j.ijpp.2021.034
14. Mittal N, Mittal R, Goel N, Parmar A, Bahl A, Kaur S, Gudibanda KR, Dudhraj V, Singh SK. WHO-Point Prevalence Survey of Antibiotic Use Among Inpatients at a Core National Antimicrobial Consumption Network Site in North India: Findings and Implications. Microb Drug Resist. 2023;29(1):1-9. doi:10.1089/mdr.2022.0170.
15. Shaikh, Q.; Sarfaraz, S.; Rahim, A.; Hussain, A.; Behram, S.; Kazi, A.S.; Hussain, M.; Salahuddin, N. WHO Point Prevalence Survey to Describe the Use of Antimicrobials at a Tertiary Care Center in Pakistan: A Situation Analysis for Establishing an Antimicrobial Stewardship Program. Antibiotics 2022, 11, 1555. https://doi.org/10.3390/antibiotics11111555
16. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195-283. doi:10.2146/ajhp120568.
17. Rashid MM, Akhtar Z, Chowdhury S, Islam MA, Parveen S, Ghosh PK, Rahman A, Khan ZH, Islam K, Debnath N, et al. Pattern of Antibiotic Use among Hospitalized Patients according to WHO Access, Watch, Reserve (AWaRe) Classification: Findings from a Point Prevalence Survey in Bangladesh. Antibiotics. 2022; 11(6):810. https://doi.org/10.3390/antibiotics11060810
18. World Health Organization. WHO Model List of Essential Medicines: 2023, 22nd list. WHO-MHP-HPS-EML-2023.04 [Internet]. Geneva: World Health Organization; 2023 [cited 2025 Jan 30]. Available from: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.04
19. Ambreen S, Safdar N, Ikram A, Baig MZI, Farooq A, Amir A, Saeed A, Sabih F, Ahsan Q, Zafar A, et al. Point Prevalence Survey of Antimicrobial Use in Selected Tertiary Care Hospitals of Pakistan Using WHO Methodology: Results and Inferences. Medicina. 2023; 59(6):1102. https://doi.org/10.3390/medicina59061102
20. Pauwels, I.; Versporten, A.; Drapier, N.; Vlieghe, E.; Goossens, H.; Koraqi, A.; Hoxha, I.; Tafaj, S.; Cornistein, W.; Quiros, R.; et al. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access,Watch and Reserve classification (AWaRe): Results from a worldwide point prevalence survey in 69 countries. J. Antimicrob. Chemother. 2021, 76, 1614–1624.